[go: up one dir, main page]

MX2012007836A - Derivados de acido carboxilico heterociclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida. - Google Patents

Derivados de acido carboxilico heterociclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida.

Info

Publication number
MX2012007836A
MX2012007836A MX2012007836A MX2012007836A MX2012007836A MX 2012007836 A MX2012007836 A MX 2012007836A MX 2012007836 A MX2012007836 A MX 2012007836A MX 2012007836 A MX2012007836 A MX 2012007836A MX 2012007836 A MX2012007836 A MX 2012007836A
Authority
MX
Mexico
Prior art keywords
carboxylic acid
acid derivatives
heterocyclic carboxylic
oxazolopyrimidine ring
substituted oxazolopyrimidine
Prior art date
Application number
MX2012007836A
Other languages
English (en)
Inventor
Matthias Schaefer
Dieter Kadereit
Stephanie Hachtel
Axel Dietrich
Thomas Huebschle
Katrin Hiss
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MX2012007836A publication Critical patent/MX2012007836A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a compuestos de oxazolopirimidina de la fórmula I, (ver fórmula (I)) en la que A, R1, R2 y R3 se definen como se ha indicado en las reivindicaciones. Los compuestos de la fórmula I son adecuados, por ejemplo, para la curación de heridas.
MX2012007836A 2010-01-14 2011-01-12 Derivados de acido carboxilico heterociclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida. MX2012007836A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10305043 2010-01-14
PCT/EP2011/050302 WO2011086080A1 (de) 2010-01-14 2011-01-12 Heterocyclische carbonsäurederivate mit einem 2,5-substituierten oxazolopyrimidinring

Publications (1)

Publication Number Publication Date
MX2012007836A true MX2012007836A (es) 2012-07-30

Family

ID=41820700

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012007836A MX2012007836A (es) 2010-01-14 2011-01-12 Derivados de acido carboxilico heterociclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida.

Country Status (20)

Country Link
US (1) US8846690B2 (es)
EP (1) EP2523960B1 (es)
JP (1) JP5841068B2 (es)
KR (1) KR101759127B1 (es)
CN (1) CN102834399B (es)
AR (1) AR079884A1 (es)
AU (1) AU2011206616B2 (es)
BR (1) BR112012017447B1 (es)
CA (1) CA2804128C (es)
DK (1) DK2523960T3 (es)
ES (1) ES2437471T3 (es)
IL (1) IL220718A (es)
MX (1) MX2012007836A (es)
MY (1) MY156476A (es)
PT (1) PT2523960E (es)
RU (1) RU2559896C2 (es)
SG (1) SG182474A1 (es)
TW (1) TWI482623B (es)
UY (1) UY33180A (es)
WO (1) WO2011086080A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY33176A (es) 2010-01-13 2011-08-31 Sanofi Aventis Derivados de oxazolopirimidina sustituida en 2, 5, 7.
UY33177A (es) 2010-01-13 2011-08-31 Sanofi Aventis Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido
CA2784560C (en) * 2010-01-14 2017-12-05 Sanofi Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
CN102834400B (zh) 2010-01-14 2015-06-10 赛诺菲 2,5-取代的*唑并嘧啶衍生物
US9309019B2 (en) 2010-05-21 2016-04-12 Adhezion Biomedical, Llc Low dose gamma sterilization of liquid adhesives
US9321787B2 (en) 2011-07-07 2016-04-26 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679682A (en) * 1970-04-23 1972-07-25 Fmc Corp CERTAIN 5H-ISOXAZOLO{8 5,4-d{9 PYRIMIDIN-4-ONES
ES2392167T3 (es) * 2003-04-30 2012-12-05 Novartis Ag Derivados aminopropanol como moduladores del receptor esfingosina-1-fosfato
US7462629B2 (en) * 2003-05-19 2008-12-09 Irm Llc Immunosuppressant compounds and compositions
AR044402A1 (es) * 2003-05-19 2005-09-14 Irm Llc Compuestos heterociclicos y su uso como inmunodepresores. composiciones farmaceuticas que los contienen.
JP2009506046A (ja) * 2005-08-23 2009-02-12 アイアールエム・リミテッド・ライアビリティ・カンパニー 免疫抑制剤化合物および組成物
US7855193B2 (en) * 2005-11-23 2010-12-21 Epix Pharmaceuticals, Inc. S1P receptor modulating compounds and use thereof
JP5191497B2 (ja) 2007-03-21 2013-05-08 エピックス ファーマシューティカルズ，インコーポレイテッド Ｓ１ｐ受容体調節化合物およびその使用
TW201000099A (en) * 2008-06-20 2010-01-01 Amgen Inc S1P1 receptor agonists and use thereof
KR20110042286A (ko) * 2008-07-15 2011-04-26 사노피-아벤티스 Ｅｄｇ－１ 수용체 작용제로서의 옥사졸로피리미딘
UY33177A (es) * 2010-01-13 2011-08-31 Sanofi Aventis Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido
UY33176A (es) * 2010-01-13 2011-08-31 Sanofi Aventis Derivados de oxazolopirimidina sustituida en 2, 5, 7.
TWI517851B (zh) * 2010-01-13 2016-01-21 賽諾菲阿凡提斯公司 含２，５，７－經取代唑并嘧啶環之雜環羧酸衍生物
CN102834400B (zh) * 2010-01-14 2015-06-10 赛诺菲 2,5-取代的*唑并嘧啶衍生物
CA2784560C (en) * 2010-01-14 2017-12-05 Sanofi Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring

Also Published As

Publication number Publication date
KR101759127B1 (ko) 2017-07-18
IL220718A (en) 2015-02-26
RU2559896C2 (ru) 2015-08-20
ES2437471T3 (es) 2014-01-10
MY156476A (en) 2016-02-26
EP2523960A1 (de) 2012-11-21
TW201134474A (en) 2011-10-16
EP2523960B1 (de) 2013-10-16
US8846690B2 (en) 2014-09-30
UY33180A (es) 2011-08-31
US20130072502A1 (en) 2013-03-21
DK2523960T3 (da) 2014-01-20
KR20120101731A (ko) 2012-09-14
PT2523960E (pt) 2013-12-09
JP2013517242A (ja) 2013-05-16
RU2012134548A (ru) 2014-02-20
TWI482623B (zh) 2015-05-01
SG182474A1 (en) 2012-08-30
HK1178886A1 (en) 2013-09-19
WO2011086080A1 (de) 2011-07-21
BR112012017447A2 (pt) 2016-04-19
CA2804128A1 (en) 2011-07-21
CN102834399B (zh) 2015-04-22
AU2011206616B2 (en) 2016-06-16
CA2804128C (en) 2017-12-12
AR079884A1 (es) 2012-02-29
CN102834399A (zh) 2012-12-19
JP5841068B2 (ja) 2016-01-06
BR112012017447B1 (pt) 2019-10-29
AU2011206616A1 (en) 2012-08-02

Similar Documents

Publication Publication Date Title
NZ601121A (en) 5-alkynyl-pyrimidines
TW201129565A (en) Tricyclic heterocyclic compounds, compositions and methods of use thereof
MX2012006805A (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa.
NZ597517A (en) 5-fluoropyrimidinone derivatives
PH12012501546A1 (en) Substituted pyrrolidine-2-carboxamides
MX2012008141A (es) Compuestos y metodos.
MY156525A (en) 2,5,7-substituted oxazolopyrimidine derivatives
MY150778A (en) Fused heterocyclic compound
MA33937B1 (fr) Composes pyrazole comme antagonistes du recepteur crth2
MX2011007998A (es) Nuevos herbicidas.
MY161132A (en) Novel herbicides
UA107784C2 (en) Inhibitor of melanin production
NZ597483A (en) N1-substituted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
MX2011007932A (es) Herbicidas nuevos.
NZ597570A (en) N1-acyl-5-fluoropyrimidinone derivatives
WO2011047055A3 (en) Novel mek inhibitors, useful in the treatment of diseases
MX2011008360A (es) Derivados de piridazinona sustituida con heteroarilo.
MX2012007836A (es) Derivados de acido carboxilico heterociclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida.
PH12012501265A1 (en) Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
MY156960A (en) Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
MX2012007833A (es) Derivados de acido carboxilico heterociclicos que contienen un anillo de oxazolopirimidina 2, 5, 7 - sustituido.
PH12015501146A1 (en) Hydantoin derivative
MX2012007837A (es) Derivados de oxazolopirimidina 2, 5 - sustituidos.
MX359399B (es) Inhibidores de 17alfa-hidroxilasa/c17-20-liasa.
MX2013010006A (es) Derivados de sec-hidroxiciclohexilo como inhibidores de lipasa sensible a hormonas (hsl) para el tratamiento de diabetes.

Legal Events

Date Code Title Description
FG Grant or registration